News | August 19, 2024
Aptar’s nasal unidose system delivers FDA-approved neffy
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Nearly 200 participants from 50 Unani Academia and Council participated
Revolutionary technology will further boost OneSource’s scientific services offerings
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Launch of 20 new medicines expected by 2030
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
More than 10,000 scientific publications containing EUDRAGIT
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Subscribe To Our Newsletter & Stay Updated
